Digenic variants in the FGF21 signaling pathway associated with severe insulin resistance and pseudoacromegaly

Authors

Stephen I Stone, Washington University School of Medicine in St. Louis
Daniel J Wegner, Washington University School of Medicine in St. Louis
Jennifer A Wambach, Washington University School of Medicine in St. Louis
F Sessions Cole, Washington University School of Medicine in St. Louis
Fumihiko Urano, Washington University School of Medicine in St. Louis
David M Ornitz, Washington University School of Medicine in St. Louis

Journal

Journal of the Endocrine Society

Publication Date

9-22-2020

Volume

4

Issue

12

First Page

bvaa138

Document Type

Open Access Publication

DOI

10.1210/jendso/bvaa138

Rights and Permissions

Stone SI, Wegner DJ, Wambach JA, Cole FS, Urano F, Ornitz DM. Digenic Variants in the FGF21 Signaling Pathway Associated with Severe Insulin Resistance and Pseudoacromegaly. J Endocr Soc. 2020 Sep 22;4(12):bvaa138. doi: 10.1210/jendso/bvaa138 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Stone, Stephen I; Wegner, Daniel J; Wambach, Jennifer A; Cole, F Sessions; Urano, Fumihiko; and Ornitz, David M, "Digenic variants in the FGF21 signaling pathway associated with severe insulin resistance and pseudoacromegaly." Journal of the Endocrine Society. 4, 12. bvaa138 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/12000